CD79A and Alzheimer disease: The post hoc analysis revealed that these differences were due to the reduced Q-IgG in the TTH patients compared to AD patients (p = 0.002) and in the slight decrease in CSF IgA in ALS patients compared to AD patients (p = 0.043); all other groups were pairwise comparable.